Shares of Syngene International opened up green on 27 July, Thursday, after the company reported a robust quarterly report for the June quarter on 26...
Strides Pharma Science on Monday declared that it had entered a binding contract to sell the biologics Unit-3 manufacturing facility of its associate company Stelis...
Syngene International’s research subsidiary of pharmaceutical giant Biocon’s shares, rose 6% on October 19 after a strong earnings performance in the September quarter. The stock...
Drugmaker Biocon sold a 5.4% stake in its research unit Syngene International for just over Rs 1,220 crore in an open market transaction on Tuesday....
Syngene International has tied up with Zumutor Biologics, for Biotherapeutic antibody services. It has entered into a non-exclusive partnering agreement with Zumutor Biologics, to access Zumutor’s proprietary...